Should Degarelix Be Accompanied By An Antiandrogen?
On the Advanced Prostate Cancer Listserv there was a question raised about the need to use an antiandrogen (bicalutamide/Casodex, flutamide/Eulexin, or nilutamide/Nilandron) along with degarelix, the recently approved LHRH antagonist (a drug that halts the [...]
Degarelix Shows Promise as Second-Line Hormonal Therapy for Men With Prostate Cancer
When Degarelix (FIRMAGON) which is a gonadotrophin-releasing hormone (GnRH) receptor blocker was first approved by the Food and Drug Administration (FDA) I contacted Ferring Pharmaceuticals and spoke with their medical director. I asked if Degarelix [...]
Should I go on to Hormone Therapy – What about the Risk of Thromboembolic Diseases
(Results from the population-based PCBaSe Sweden) Hormone therapy (ADT) is designed to prevent the manufacturing of testosterone however, testosterone is a very important preventive hormone, especially in the area of heart health. ADT also causes [...]
Malecare Advanced Prostate Cancer Teleconference
Join us for a conversation about treating advanced stage prostate cancer, with James M. McKiernan, M.D. and Joel Nowak, M.A., M.S.W. […]
Medicare/ Trailblazer Rejects Reimbursement for Provenge & Jevtana!
A member of the advanced prostate cancer on-line support group who is the wife of an advanced prostate cancer survivor in New Mexico just informed us that Trailblazer (the MAC that controls New Mexico reimbursements [...]
Salvage Radiotherapy after High-Intensity Focused Ultrasound (HIFU) for Recurrent Localized Prostate Cancer
HIFU has been a common primary prostate cancer treatment in Europe for quite a while. Currently, in the United States, there are a number of clinical trial sites evaluating HIFU as a primary treatment. Like [...]